Pulmonary Arterial Hypertension Life Expectancy & Survival Rates

The treatment for Pulmonary Arterial Hypertension has come a long way since the mid 1990’s when Flolan was first approved.  There has been an explosion of new medications that have dramatically altered how we treat patients.  We no longer sequentially add therapies to most of our patients.  Rather, we often start two or even three different therapies as part of an initial … [Read more...]

Help Arrives for Some PAH Patients Who Can’t Afford Their Medication

Thousands of Pulmonary Arterial Hypertension patients across America are now experiencing a crisis.  They previously received support from Caring Voices Coalition. With the closing of Caring Voices, many of these patients have been unable to find foundation support, leaving them responsible for many thousands of dollars per month to receive their PAH medications. The PHA and … [Read more...]

Update on the Implantable System for Remodulin

On December 22, 2017, after eight years of study, the FDA has finally granted pre-market approval (PMA) to the fully implantable system for Remodulin.  This groundbreaking pump and catheter system allows patients to benefit from Remodulin while minimizing the inconvenience and risks associated with having an external intravenous catheter. However, this does not mean that the … [Read more...]

Financial Assistance for Pulmonary Hypertension Patients with Medicare, Medicaid & Military Benefits

  Assistance Now Available. Where to get financial assistance for the very expensive drugs used to treat Pulmonary Arterial Hypertension remains a hot topic. With an average treatment cost of around $100,000 per PAH patient per year, financial assistance is in great demand. Pulmonary Hypertension patients that are uninsured or privately insured have options for financial … [Read more...]

Stimulant Associated Pulmonary Arterial Hypertension

Diet Pills and Methamphetamines Stimulants were first suspected of causing pulmonary hypertension in the late 1960’s and early 1970’s.  In Austria a diet pilled called Aminorex was marketed in the late 1960’s and shortly thereafter an epidemic of pulmonary arterial hypertension developed among users.  The pill was withdrawn in the early 1970’s and the wave of Aminorex … [Read more...]